CXHB1700120 | TPN729MA | TPN729MA | Other | Chemical Drugs | Supplementary Application | 2018-03-09 | 天方药业有限公司 | Topfond Pharmaceutical Co Ltd | In Review | 2018-03-07 | view |
CXHL1100733 | TPN729MA | TPN729MA | Other | Chemical Drugs(1.1) | New Drug Application | 2012-01-29 | 河南天方药业股份有限公司 | Henan Topfond Pharmaceutical Co Ltd | Certificate Issued | 2013-07-09 | view |
CXHB1700122 | TPN729MA片 | TPN729MA | Tablet | Chemical Drugs | Supplementary Application | 2018-03-09 | 天方药业有限公司 | Topfond Pharmaceutical Co Ltd | Certificate Issued | 2018-07-24 | view |
CXHL1100734 | TPN729MA片 | TPN729MA | Tablet | Chemical Drugs(1.1) | New Drug Application | 2012-01-29 | 河南天方药业股份有限公司 | Henan Topfond Pharmaceutical Co Ltd | Certificate Issued | 2013-07-09 | view |
CXHL1100735 | TPN729MA片 | TPN729MA | Tablet | Chemical Drugs(1.1) | New Drug Application | 2012-01-29 | 河南天方药业股份有限公司 | Henan Topfond Pharmaceutical Co Ltd | Certificate Issued | 2013-07-09 | view |
CXHB1700121 | TPN729MA片 | TPN729MA | Tablet | Chemical Drugs | Supplementary Application | 2018-03-09 | 天方药业有限公司 | Topfond Pharmaceutical Co Ltd | Certificate Issued | 2018-07-24 | view |